HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$1.62
Day range
$1.56 - $1.60
Year range
$1.21 - $23.80
Market cap
3.55M USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.64M | -23.57% |
Net income | -3.21M | -59.18% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.64M | 23.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.33M | 21.27% |
Total assets | 18.50M | 11.25% |
Total liabilities | 2.17M | -20.98% |
Total equity | 16.33M | — |
Shares outstanding | 2.26M | — |
Price to book | 0.17 | — |
Return on assets | -20.84% | — |
Return on capital | -23.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.21M | -59.18% |
Cash from operations | -1.97M | -119.27% |
Cash from investing | -3.55M | -255.73% |
Cash from financing | 448.00K | — |
Net change in cash | -5.07M | -467.13% |
Free cash flow | -1.88M | -692.73% |
About
Founded
2000
Website
Employees
5
